Wang Jufeng: Clinical Trials

1 trial sponsored by Wang Jufeng, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Wang Jufeng: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancer
Thalidomide, CPT-11 - Gastric Cancer
Phase 4UnknownWang Jufeng9002014-08-012015-03-30

Conditions studied

Stomach Neoplasms (1)

Interventions

Irinotecan (1)  ·  Thalidomide (1)

Countries

China (1)

Top investigators

Guo Yanzhen (1)  ·  Qin Yanru (1)  ·  Zhang Zhongmian (1)  ·  Zhou Yun (1)